CFA
GDRX icon

Carroll Financial Associates’s GoodRx Holdings GDRX Stock Holding History

Carroll Financial Associates’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3
Closed – – 1736
2021
Q3 		$0 Sell
3
-5
-63% -$181 ﹤0.01% 1825
2021
Q2 		$0 Buy
+8
New +$295 ﹤0.01% 1741

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Abdiel Capital Advisors New York $52M AUM 13.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $795M AUM 5.23% 1-Year Est. Return

Carroll Financial Associates's GDRX Position: Q4 2021 in Review

Carroll Financial Associates sold out of GoodRx Holdings (GDRX) in Q4 2021, closing a stake of 3 shares.

Carroll Financial Associates first reported a position in GDRX in Q2 2021 and held it in 2 quarters. The position peaked at $0 in Q3 2021. 216 funds tracked by Wall St. Rank hold GDRX as of Q4 2021.

  • Carroll Financial Associates reported no remaining GoodRx Holdings position as of Q4 2021 after selling out during the quarter.
  • Carroll Financial Associates sold 3 GoodRx Holdings shares in Q4 2021.
  • Carroll Financial Associates first reported a position in GoodRx Holdings in Q2 2021 and held it in 2 quarters.
  • Carroll Financial Associates's GoodRx Holdings position peaked at $0 in Q3 2021.
  • 216 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.